Anticuerpos monoclonales
Adecatumumab
Cixutumumab
Conatumumab
Daratumumab
Drozitumab
Duligotumab
Dusigitumab
Figitumumab
Ganitumab
Glembatumumab vedotin
Intetumumab
Iratumumab
Lexatumumab
Lucatumumab
Mapatumumab
Narnatumab
Necitumumab
Ofatumumab
Olaratumab
Patritumab
Pritumumab
Radretumab
Rilotumumab
Robatumumab
Teprotumumab
Tovetumab
Vantictumab
Votumumab
Zalutumumab

Flanvotumab
Altumomab pentetate
Anatumomab mafenatox
Arcitumomab
Bectumomab
Blinatumomab
CC49
Detumomab
Ibritumomab tiuxetan
Minretumomab
Mitumomab
Moxetumomab pasudotox
Naptumomab estafenatox
Nofetumomab merpentan
Pemtumomab †
Pintumomab
Racotumomab
Satumomab pendetide
Solitomab
Taplitumomab paptox
Tenatumomab
Tositumomab
3F8

Abagovomab · Igovomab · Oregovomab
Capromab pendetide
Edrecolomab · Nacolomab tafenatox
CHIMERIC (“-TUXI-“)
Amatuximab
Bavituximab
Brentuximab vedotin
Cetuximab
Ensituximab
Futuximab
Girentuximab
Indatuximab ravtansine
Margetuximab
Rituximab
Siltuximab
Ublituximab
“-mexi-” (melanoma ): Ecromeximab
HUMANIZED (“-TUZU-“)
Obinutuzumab
Alemtuzumab
Bevacizumab
Bivatuzumab mertansine
Cantuzumab mertansine
Cantuzumab ravtansine
Citatuzumab bogatox
Clivatuzumab tetraxetan
Dacetuzumab
Dalotuzumab
Elotuzumab †
Etaracizumab
Farletuzumab
Ficlatuzumab
Gemtuzumab ozogamicin
Imgatuzumab
Inotuzumab ozogamicin
Labetuzumab
Lintuzumab
Lorvotuzumab mertansine
Matuzumab §
Milatuzumab
Nimotuzumab
Ocaratuzumab
Onartuzumab
Oportuzumab monatox
Parsatuzumab
Pertuzumab
Sibrotuzumab
Simtuzumab
Tacatuzumab tetraxetan
Tigatuzumab
Trastuzumab
Tucotuzumab celmoleukin
Veltuzumab
Vorsetuzumab mafodotin

Catumaxomab
Ertumaxomab

Ontuxizumab

INHIBIDORES DE TIROSINA KINASA

Erlotinib

Sunitinib

Imotinib

Pegatanib

Gefitinib

Sorafenib

Dasatinib

Nilotinib

Lapatinib

Valatanib

Vandetanib

Panitumumab

Ranibizumab

Trastuzumab

Cetuximab

COMPUESTOS DE PLATINO

Cisplatino

Carboplatino

ANTIMETABOLITOS